
    
      Pregnant individuals carrying at least one HbS allele will be included in the study to
      collect the umbilical cord blood of the child at birth. Collected cells will be used
      anonymously for genetic and bioexperimental laboratory research, aiming to develop autologous
      gene therapy for sickle cell disease.
    
  